South Africa has launched its first-ever human HIV vaccine trial. It is a landmark for a country that remains the global epicentre of HIV. The long-term ambition is clear. Scientists want a safe, affordable vaccine given in the first year of life, with no need for repeat doses. The trial, known as BRILLIANT 011, is a first-in-human study. It has…